pharma · Solid Tumors · Primary Dysmenorrhea
Topiloric/Uriadec
Topiloric/Uriadec is a pharma organization headquartered in SOUTH SAN FRANCISCO, CA, JP. Primary therapeutic focus areas include Solid Tumors, Primary Dysmenorrhea, Prostate cancer, chronic liver disease, Prostatic Neopl
SOUTH SAN FRANCISCO, CA, JP HQ
2 Employees
PMDA registrant Type
Company details
- Status
- Public
- HQ
- SOUTH SAN FRANCISCO, CA, JP
- Employees
- 2
- Programs
- 12
- Drugs
- 7
- Patents
- 52
Ph 1 Study of ORIC-944 in Patients with Metastatic Prostate Cancer.
Phase 1 · other · Prostate cancer
Ph 1 Study of ORIC-944 in Patients with Metastatic Prostate Cancer. for Prostate cancer is a Phase 1 program (other) at Topiloric/Uriadec with 1 ClinicalTrials.gov record(s).
Internal code ORIC-944-01
Full intelligence profile for this program is being prepared.
At a glance
- Sponsor
- Topiloric/Uriadec
- Phase
- Phase 1
- Modality
- other
- Indication
- Prostate cancer
- Status
- active
- Trials
- 1